Aug. 30, 2004 — A short course of the tumor necrosis factor-α (TNF-α) inhibitor etanercept results in more sustained improvement in severe sciatica than standard care, according to the results of a ...
Tobinick EL and Gross H (2008) Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation 5: 2 A substantial amount of evidence indicates ...
Tumor necrosis factor-alpha (TNF) is one of a number of systemic and immunomodulating cytokines that generally act to promote acute-phase reactions but can drive degenerative changes when chronically ...
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than ...
Investigators found a slightly increased risk for serious infection among patients with juvenile idiopathic arthritis who took first-line etanercept or adalimumab compared with patients who took ...
Etanercept can bind to and neutralize extracellular tumor necrosis factor, and has proven clinical efficacy in reducing the disease symptoms of patients with rheumatoid arthritis (RA) who cannot ...
A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, ...
This is a preview. Log in through your library . Abstract Objective To estimate the cost-effectiveness, from a Swedish societal perspective, of intermittent use of etanercept (Enbrel) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results